Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

The public looks at synthetic biology — cautiously

By R&D Editors | September 8, 2010

The public looks at synthetic biology — cautiously

WASHINGTON, DC: Synthetic biology – defined as the design and construction of new biological parts, devices, and systems or re-design of existing natural biological systems for useful purposes – holds enormous potential to improve everything from energy production to medicine, with the global market projected to reach $4.5 billion by 2015. But what does the public know about this emerging field, and what are their hopes and concerns? A new poll of 1,000 U.S. adults conducted by Hart Research Associates and the Synthetic Biology Project at the Woodrow Wilson Center finds that two-thirds of Americans think that synthetic biology should move forward, but with more research to study its possible effects on humans and the environment, while one-third support a ban until we better understand its implications and risks. More than half of Americans believe the federal government should be involved in regulating synthetic biology.

“The survey clearly shows that much more attention needs to be paid to addressing biosafety and biosecurity risks,” said David Rejeski, Director of the Synthetic Biology Project. “In addition, government and industry need to engage the public about the science and its applications, benefits, and risks.”

The poll findings reveal that the proportion of adults who say they have heard a lot or some about synthetic biology has almost tripled in three years, (from 9 percent to 26 percent). By comparison, self-reported awareness of nanotechnology increased from 24 percent to 34 percent during the same three-year period.

Although the public supports continued research in the area of synthetic biology, it also harbors concerns, including 27 percent who have security concerns (concerns that the science will be used to make harmful things), 25 percent who have moral concerns, and a similar proportion who worry about negative health consequences for humans. A smaller portion, 13 percent, worries about possible damage to the environment.

“The survey shows that attitudes about synthetic biology are not clear-cut and that its application is an important factor in shaping public attitudes towards it,” said Geoff Garin, President of Hart Research. Six in 10 respondents support the use of synthetic biology to produce a flu vaccine. In contrast, three-fourths of those surveyed have concerns about its use to accelerate the growth of livestock to increase food production. Among those for whom moral issues are the top concern, the majority views both applications in a negative light.

The findings come from a nationwide telephone survey of 1,000 adults and has a margin of error of ± 3.1 percentage points. This is the fifth year that Hart Research Associates has conducted a survey to gauge public opinion about nanotechnology and/or synthetic biology for the Woodrow Wilson International Center for Scholars.

SOURCE

Related Articles Read More >

R&D 100 winner of the day: Electromagnetic spectrum management system (ESMS)
Claude computer use
AI agents could begin transforming how we work in 2025
refinery
AI takes center stage in Honeywell-Chevron collaboration
Firefly blurred lines between a human and machine researcher 72875
Copyleaks CEO: OpenAI’s o1 emergence could blur the lines between human researcher and AI assistant
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE